pharma · Infertility in women undergoing assisted reproductive technologies (ART) · Intermediate risk, non-muscle invasive bladder cancer
Ferring Pharmaceuticals
Ferring Pharmaceuticals clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- -, St-Prex, 1162, CH, Mumbai
- Founded
- 1950
- Employees
- 6,228
- Programs
- 13
- Drugs
- 23
- Patents
- 0
Ferring Pharmaceuticals projects
4 ClinicalTrials.gov programs sponsored by Ferring Pharmaceuticals.
Ferring Pharmaceuticals has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
000414
Ferring Pharmaceuticals
Inflammatory Gastrointestinal Disease
1 trial -
000426
Ferring Pharmaceuticals
Infertility in women undergoing assisted reproductive technologies (ART)
1 trial -
000427
Ferring Pharmaceuticals
Infertility in women undergoing assisted reproductive technologies (ART)
1 trial -
Budesonide
Ferring Pharmaceuticals
Healthy
1 trial
Frequently asked questions
How many clinical projects does Ferring Pharmaceuticals have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.